ABBV

Abbvie Inc

• TipRanks·3h ago

  AbbVie’s RINVOQ Safety Study In Japan: What The Latest Update Means For ABBV Investors

• TipRanks·5h ago

  Analysts’ Top Healthcare Picks: TG Therapeutics (TGTX), AbbVie (ABBV)

• Simply Wall St·8h ago

  The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of AQUIPTA For Acute Migraine

• Barron‘s·12h ago

  Getting Alzheimer's Drugs Into the Brain Is Hard. Now There's a New Trick.

• The Motley Fool·1d ago

  Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic

• Seeking Alpha·1d ago

  AT&T stock keeps falling: Is heavy fiber spending weighing on strong outlook?

• NASDAQ·1d ago

  Notable ETF Inflow Detected - USCL, ORCL, PLTR, ABBV

• The Motley Fool·1d ago

  The S&P 500 Is Expensive, but These 3 Dividend Stocks Still Look Like Bargains

• TipRanks·1d ago

  Analysts Offer Insights on Healthcare Companies: Astellas Pharma (OtherALPMF), AbbVie (ABBV) and Replimune Group (REPL)

• PR Newswire·1d ago

  AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

• Seeking Alpha·1d ago

  AbbVie gains EU approval of atogepant for acute migraine

• The Motley Fool·1d ago

  3 Dividend Stocks to Buy and Hold Forever

• The Motley Fool·2d ago

  AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

• TipRanks·2d ago

  Piper Sandler Reaffirms Their Buy Rating on AbbVie (ABBV)

• Simply Wall St·2d ago

  Natera And 2 Other Companies That May Be Trading Below Their Estimated Value